{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Interventions for Adult and Pediatric Leukemia Patients
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To present the latest information about new treatment options for adult and pediatric patients who have leukemia.Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize new treatment options for adults with leukemia.
- Identify a novel strategy for choosing an alternative source of stem cells for hematopoietic stem cell transplantation (SCT) for children with acute leukemia.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$24.95
Credits:
- ANCC 2.5 CH
- DC - BON 2.5 CH
- KY-BON 2.5 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0314
Published: Mar 2014
Expires: 12/31/2026
Sources:
Oncology Times
Required Passing Score: 11/15 (73%)